Back

Major bleeding complications and antithrombotic treatment after isolated surgical bioprosthetic aortic valve replacement

30 August 2024 (09:00 - 09:40)
Organised by: Logo
Congress Presentation Part of: Prosthetic heart valves: preventing thrombosis and stroke Prosthetic Heart Valves ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Rikhard Bjorn

Turku University Hospital, Turku (Finland)

6 More presentations in this session

Presentation thumbnail
Impact of protruding and ulcerated aortic atheroma on periprocedural ischemic stroke in patients undergoing transcatheter aortic valve replacement: a comprehensive analysis
Doctor S. Kikuchi (Strasbourg, FR)
Abstract Slides Video
Presentation thumbnail
Association between silent cerebral embolism and cognitive alterations following transcatheter aortic valve replacement in bicuspid versus tricuspid aortic valve patients
Doctor Y. Huang (Changsha, CN)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of the ultraslow low-dose thrombolytic regimen for mechanical prosthetic valve thrombosis: a prospective cohort study
Professor P. Sadeghipour (Tehran, IR)
Abstract Slides Video
Presentation thumbnail
Anticoagulation control challenges in patients with rheumatic heart disease and mechanical heart valves operated at a cardiac surgery center in a low-income country
Mrs C. Nhavoto (Maputo, MZ)
Abstract Slides Video
Presentation thumbnail
Surgery versus thrombolytic therapy for the management of left-sided prosthetic valve thrombosis without hemodynamic compromise: a systematic review and meta-analysis
Doctor R. Chopard (Besancon, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Prosthetic heart valves: preventing thrombosis and stroke

The Event

Event poster

ESC Congress 2024

30 August 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Bleeding risk stratification in patients undergoing transcatheter aortic valve replacement: enhancing VARC-HBR criteria with CT-ADP as a marker of primary hemostatic disorder
thumbnail
Congress Presentation
Safety and efficacy of prolonged antithrombotic therapy in high-risk patients followed in a dedicated secondary prevention consultation
thumbnail
Congress Presentation
POPular PAUSE TAVI - Continuation or interruption of oral anticoagulation during TAVI?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources